ALLMedicine™ Osteochondral Lesions Of The Talus Center

Feb 23rd, 2021 - The purpose of this study is to systematically review the literature and to evaluate the outcomes following bone marrow stimulation (BMS) for nonprimary osteochondral lesions of the talus (OLT). A literature search was performed to identify studie...

Feb 19th, 2021 - To evaluate at long-term follow-up patients undergoing a one-step procedure of debridement and BMAC seeded in situ onto a scaffold for the treatment of osteochondral lesions of the talus (OLT) in ankles affected by osteoarthritis (OA), documenting...

Feb 1st, 2021 - The management of symptomatic osteochondral lesions of the talus (OLTs) can be challenging. The number of ways of treating these lesions has increased considerably during the last decade, with published studies often providing conflicting, low-lev...

Jan 25th, 2021 - Osteochondral lesions of the talus (OLTs) are characterized by damage to the articular cartilage of the talus and its underlying subchondral bone. Up to 75% of OLTs are caused by trauma, such as an ankle sprain or fracture. Physical examination an...

Jan 25th, 2021 - In the past 2 decades, there has been a rapid expansion of clinical studies investigating the safety and efficacy of biological treatment methods for a wide range of diseases. These biological treatment methods increasingly are used in clinical pr...

Sep 14th, 2018 - Treatment guidelines for cartilage lesions of the talus have been based on both low quality and low levels of evidence. Therefore, an international consensus group of experts was convened to collaboratively advance toward consensus opinions on key...

Feb 23rd, 2021 - The purpose of this study is to systematically review the literature and to evaluate the outcomes following bone marrow stimulation (BMS) for nonprimary osteochondral lesions of the talus (OLT). A literature search was performed to identify studie...

Feb 19th, 2021 - To evaluate at long-term follow-up patients undergoing a one-step procedure of debridement and BMAC seeded in situ onto a scaffold for the treatment of osteochondral lesions of the talus (OLT) in ankles affected by osteoarthritis (OA), documenting...

Feb 1st, 2021 - The management of symptomatic osteochondral lesions of the talus (OLTs) can be challenging. The number of ways of treating these lesions has increased considerably during the last decade, with published studies often providing conflicting, low-lev...

Jan 25th, 2021 - Osteochondral lesions of the talus (OLTs) are characterized by damage to the articular cartilage of the talus and its underlying subchondral bone. Up to 75% of OLTs are caused by trauma, such as an ankle sprain or fracture. Physical examination an...

Jan 25th, 2021 - In the past 2 decades, there has been a rapid expansion of clinical studies investigating the safety and efficacy of biological treatment methods for a wide range of diseases. These biological treatment methods increasingly are used in clinical pr...

Stem Cells Embryonic Derived Mesenchymal Cells Embryonic-derived mesenchymal cells (EMCs) are pluripotent stem cells with the ability to differentiate into all three primary germ layers: endoderm (eg, lining of the gastrointestinal tract and lungs...

Abstract and Introduction Abstract Surgical techniques for the management of recalcitrant osteochondral lesions of the talus have improved; however, the poor healing potential of cartilage may impede long-term outcomes. Repair (microfracture) or r...

Summary The optimal management of OLT is still undefined. An international consensus meeting on the treatment of OLTs was recently held at the University of Pittsburgh (M.V.H.).[35] The results of this meeting as it pertains to biologics were repo...

Abstract and Introduction Abstract Surgical techniques for the management of recalcitrant osteochondral lesions of the talus have improved; however, the poor healing potential of cartilage may impede long-term outcomes. Repair (microfracture) or r...